HC Wainwright & Co. maintains Buy rating on ACADIA Pharmaceuticals, $33 price target

HC Wainwright & Co. maintained their Buy rating on ACADIA Pharmaceuticals's stock with a price target of $33.00.The price target implies an upside of 48.8% from the Sep 24 close of $22.18.Key takeaways from the analyst noteStrong Market Position in Neurological Disorders: ACADIA Pharmaceuticals has…